THIOCETAM IN THE ACUTE PERIOD OF ISCHEMIC STROKE

Download full text PDF
Issue: 
8
Year: 
2015

K. Chizhova; Professor I. Sholomov, MD V.I. Razumovsky Saratov State Medical University

The paper gives the results of correction of endothelial dysfunction and those of an investigation of blood rheological properties in Thiocetam-treated patients in the acute period of ischemic stroke.
Keywords: 
acute cerebrovascular accident
ischemic stroke
Thiocetam

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Suslina Z.A. Insul't: diagnostika,lechenie, profilaktika. Pod red. Z.A. Suslinoj, M.A. Piradova. 2-e izd. / M.: MEDpress-inform, 2009; 288 s.
  2. Danilov V.I. Insul't. Sovremennye podhody diagnostiki, lechenija i profilaktiki: metodicheskie rekomendatsii. Pod red. V.I. Danilova, D.R. Hasanovoj / M.: GEOTAR-Media, 2014; s. 248.
  3. Troshin V.D., Gustov A.V., Troshin O.V. Ostrye narushenija mozgovogo krovoobraschenija / Nizhnij Novgorod: NGMA, 2000; 440 s.
  4. Suslina Z.A. Sosudistye zabolevanija golovnogo mozga v Rossii: real' nost' i perspektivy reshenija problemy. Materialy XIII Mezhdun. Konf. «Aktual'nye napravlenija v nevrologii». 27–29 aprelja 2011 g. Sudak. http://neurology.com.ua/2011/05/10/sosud_zabolevaniya_sudak_2011.html
  5. Vahnina N.V. Lechenie ishemicheskogo insul'ta // Rus. med. zhurn. – 2008; 16 (12): 1641.
  6. Drapkina O.M. Mozgovoj insul't: vzgljad iz terapevticheskogo okna // Consilium Medicum. – 2011; 10 (13): 119–22.
  7. Tsukurova L.A., Bursa Ju.A. Faktory riska, pervichnaja i vtorich-naja profilaktika ostryh narushe-nij mozgovogo krovoobraschenija // RMZh. «Nevrologija». – 2012; 10: 494–500.
  8. Parfenov V.A., Hasanova D.R. 8. Ishemicheskij insul't / M.: Meditsinskoe informatsionnoe agent-stvo, 2012; 288 s.
  9. Seredenko E.V. Ishemicheskij 9. insul't v ostrejshem i ostrom perio-dah. Semioticheskie aspekty narushenija tserebral'noj gemodinamiki po dan-nym perfuzionnoj spiral'noj kom-p'juternoj tomografii // Vestnik neotlozhnoj vosstanovitel'noj medi-tsiny. – 2013; 3 (14): 383–6.
  10. Belichev I.F., Mazur I.A. 10. i dr. Mesto tiotsetama sredi nootrop-nyh sredstv // Odesskij med. zhurn. – 2004; 7 (98): 5–8.
  11. Shtok V.N. Klinicheskaja farmakologija vazoaktivnyh sredstv i farmakoterapija tserebrovaskuljarnyh rasstrojstv: rukovodstvo dlja vrachej / M.: Meditsinskoe inform. agentstvo, 2009; 584 s.
  12. Tabarov M.S., Toshtemirova Z.M., Saidmuradova R.A. i dr. Fiziologija i patologija endotelija // Nauchno-meditsinskij zhurnal «Vestnik Avitsenny». – 2012; 2: 196–202.
  13. Hassan Y., Aziz N., Al-Jabi S. et al. Impact of angiotensin-converting enzyme inhibitors administration prior to acute Ischemic Stroke Onset on In-Hospital Mortality // J. Cardiovasc. Pharmacol. Ther. – 2010; 15 (3): 274–81.
  14. Wang Z., Li J., Wang C. et al. Gender differences in 1-year clinical characteristics and outcomes after stroke: Results from the China national stroke registry // PloS One. – 2013; 8 (2): e56459.
  15. Kissela B., Khoury J., Alwell K. et al. Ageatstroke: Temporal trends in stroke incidence in a large, biracial population // Neurology. – 2012; 79: 1781–7.